Fusion Medical Animation

Gene Editing

EDIT-301: An investigational gene editing medicine for the treatment of severe sickle cell disease and transfusion-dependent beta thalassemia.

In patients with severe sickle cell disease, sickle-shaped red blood cells lead to vaso-occlusive events, inflammation, chronic hemolytic anemia, and ischemic organ damage.
 
EDIT-301, a potential one-time, durable treatment, drives early correction of anemia and clinically meaningful improvements in patients living with severe sickle cell disease and transfusion-dependent beta thalassemia.
 

An Introduction To Opti-ox: Next Generation Cell Reprogramming.

Opti-ox: Optimized induced overexpression is a next generation technology that industrializes cell reprogramming.

Opti-ox makes use of specific locations in the DNA called genomic safe harbour sites, in which new cell type programs are inserted. Genomic safe harbours prevent gene silencing without interfering with their function.

Using these sites, opti-ox enables faithful execution of genetic programs in every cell…. so reprogramming is deterministic. 

It forces cells to switch identity.  It’s like the 'Enter' button of LifeOS.